UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

被引：99

作者：

Bird, Jenny ^{[1
]}

Behrens, Judith ^{[2
]}

Westin, Jan ^{[3
]}

Turesson, Ingemar ^{[4
]}

Drayson, Mark ^{[5
]}

Beetham, Robert ^{[6
]}

D'Sa, Shirley ^{[7
]}

Soutar, Richard ^{[8
]}

Waage, Anders ^{[9
]}

Gulbrandsen, Nina ^{[10
]}

Gregersen, Henrik ^{[11
]}

Low, Eric

机构：

[1] Bristol Haematol & Oncol Ctr, Avon Haematol Unit, Bristol, Avon, England

[2] St Helier Hosp, Dept Haematol, Surrey, England

[3] Sahlgrens Univ Hosp, Dept Haematol, Gothenburg, Sweden

[4] Malmo Univ Hosp, Dept Med, Malmo, Sweden

[5] Univ Birmingham, Div Immun & Infect, Birmingham, W Midlands, England

[6] Frenchay Hosp, Dept Clin Biochem, Bristol BS16 1LE, Avon, England

[7] UCL, Dept Haematol, London, England

[8] Glasgow Western Infirm, Glasgow, Lanark, Scotland

[9] NTNU St Olavs Hosp, Dept Haematol, Trondheim, Norway

[10] Ullevaal Univ Hosp, Dept Haematol, Oslo, Norway

[11] Aarhus Univ Hosp, Aalborg Hosp, Dept Haematol, Aalborg, Denmark

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2009年 / 147卷 / 01期

关键词：

amyloidosis; myeloma; lymphoid malignancies; immunoglobulin; laboratory haematology; SMOLDERING MULTIPLE-MYELOMA; BONE-MINERAL DENSITY; PERIPHERAL-NERVE-SOCIETY; JOINT TASK-FORCE; MALIGNANT-TRANSFORMATION; NEUROLOGICAL-SOCIETIES; EUROPEAN-FEDERATION; PROGNOSTIC-FACTORS; ADULT-POPULATION; FRACTURE RISK;

D O I：

10.1111/j.1365-2141.2009.07807.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：22 / 42

页数：21

共 70 条

[1]

ALEXANIAN R, 1975, ARCH INTERN MED, V135, P62, DOI 10.1001/archinte.135.1.62

[2] HIV-associated monoclonal gammopathy: A retrospective analysis of 25 patients [J].

Amara, Sashi ;

Dezube, Bruce J. ;

Cooley, Timothy P. ;

Pantanowitz, Liron ;

Aboulafia, David M. .

CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) :1198-1205

[3]

Avet-Loiseau H, 1999, CANCER RES, V59, P4546

[4]

AXELSSON U, 1966, ACTA MED SCAND, V179, P235

[5] MALIGNANT LYMPHOMA AND LYMPHATIC LEUKEMIA ASSOCIATED WITH MYELOMA-TYPE SERUM PROTEINS [J].

AZAR, HA ;

HILL, WT ;

OSSERMAN, EF .

AMERICAN JOURNAL OF MEDICINE, 1957, 23 (02) :239-249

[6] Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy [J].

Baldini, L ;

Guffanti, A ;

Cesana, BM ;

Colombi, M ;

Chiorboli, O ;

Damilano, I ;

Maiolo, AT .

BLOOD, 1996, 87 (03) :912-918

[7] Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss [J].

Berenson, James R. ;

Yellin, Ori ;

Boccia, Ralph V. ;

Flam, Marshall ;

Wong, Siu-Fun ;

Batuman, Olcay ;

Moezi, Mehdi M. ;

Woytowitz, Donald ;

Duvivier, Herbert ;

Nassir, Youram ;

Swift, Regina A. .

CLINICAL CANCER RESEARCH, 2008, 14 (19) :6289-6295

[8] Guidelines on the diagnosis and management of AL amyloidosis [J].

Bird, J ;

Cavenagh, J ;

Hawkins, P ;

Lachmann, H ;

Mehta, A ;

Samson, D .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (06) :681-700

[9] MALIGNANT TRANSFORMATION AND LIFE EXPECTANCY IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE [J].

BLADE, J ;

LOPEZGUILLERMO, A ;

ROZMAN, C ;

CERVANTES, F ;

SALGADO, C ;

AGUILAR, JL ;

VIVESCORRONS, JL ;

MONTSERRAT, E .

BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (03) :391-394

[10] Serum test for assessment of patients with Bence Jones myeloma [J].

Bradwell, AR ;

Carr-Smith, HD ;

Mead, GP ;

Harvey, TC ;

Drayson, MT .

LANCET, 2003, 361 (9356) :489-491

← 1 2 3 4 5 6 7 →